Waiv Secures $33 Million to Scale AI Precision Testing

Contributed by: Business Wire

Logo

Images

Business Wire embedded0

Tags

Data Management

Technology

Other Health

Health

Pharmaceutical

Oncology

Other Science

Medical Devices

Research

Artificial Intelligence

Science

$33 million financing round

More Like This

Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing

Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

PR Newswire associated0

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare

Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research

PR Newswire associated0

Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs